National Intersectoral MHPSS Emergency Preparedness And Response Plan: In The Context Of The Risk Of

National Intersectoral MHPSS Emergency Preparedness and Response Plan: In the Context of the Risk of War on Lebanon

In response to the escalating situation and war on Lebanon, the Ministry of Public Health (MoPH) has developed and is currently implementing with all stakeholders the:
“National Intersectoral MHPSS Emergency Preparedness and Response Plan: In the Context of the Risk of War on Lebanon "

Developed through a collaborative approach by the National Mental Health Programme (NMHP) with the support of the World Health Organization, UNICEF, and all MHPSS Stakeholders (please refer to the action plan for a full list), this comprehensive plan outlines a proactive approach to anticipating, mitigating, and responding to the psychosocial impacts by focusing on early intervention and support to minimize the adverse effects on individuals, healthcare personnel and communities. It underscores the commitment of the MoPH and the NMHP to safeguard mental health and respond timely and effectively to the psychosocial needs of all populations residing in Lebanon during times of crisis while promoting their resilience.

Key Features of the Plan:

Continuity of MHPSS Services: The plan highlights actions to ensure the continued availability and accessibility of MHPSS services across Lebanon.
Assurance of Psychotropic Medications: The plan emphasizes ensuring the continuous supply and access to psychotropic medications to all old and new beneficiaries.
Communication and Messaging: The plan prioritizes the development and dissemination of key messages and tips on topics related to mental health and well-being that would promote community resilience.
Training and Capacity Building: The plan places a strong emphasis on training healthcare professionals and frontline responders in MHPSS principles and practices to provide effective support to service users and providers.

The MoPH is implementing this action plan with all stakeholders, including governmental bodies, local authorities and municipalities, non-governmental organizations, healthcare providers, frontliners, and the international community - Please do reach out if your organization is interested to join in implementing this crucial plan and working together to ensure the mental health and psychosocial support of Lebanon’s residents during times of adversity.

Kindly find a selection of valuable links below:

Registration link for PFA Trainings: https://forms.gle/NzJe3mEYynuCKemr6
Key messages and videos: Link
4Ws platform: https://mhis.nmhp-lb.com/#/account/login

...

168

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05AA07	VOLUVEN	B	Starch poly(O-2-Hydroxyethyl) - 6%	6%	Injectable solution	987,724 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg		Tablet, film coated	933,971 L.L
D01AC14	DERMOFIX	B	Sertaconazole nitrate - 20mg/g	2%	Cream	382,995 L.L
J01DD07	CEFIZOX	B	Ceftizoxime (sodium) - 1g	1g	Injectable powder for solution	788,836 L.L
L01BB04	LITAK 10	B	Cladribine - 2mg/ml	2mg/ml	Injectable solution	130,295,163 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.75mg	0.75mg	Tablet, extended release	942,034 L.L
R03AK07	SYMBICORT TURBUHALER	B	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation		Inhalation powder	1,689,210 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	581,884 L.L
L01BB04	LITAK 10	B	Cladribine - 10mg/5ml	10mg/5ml	Injectable solution	39,016,157 L.L
N02BE01	DOLIPRANE	B	Paracetamol - 1,000mg	1000mg	Tablet	120,946 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.375mg	0.375mg	Tablet, extended release	473,033 L.L
R06AX29	LABIXTEN	B	Bilastine - 20mg	20mg	Tablet	584,571 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	933,971 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
G01AF12	LOMEXIN	B	Fenticonazole nitrate - 200mg	200mg	Ovule	810,359 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	581,884 L.L
L01BB04	MAVENCLAD	B	Cladribine - 10mg	10mg	Tablet	200,244,812 L.L
N02BE01	DOLIPRANE	B	Paracetamol - 1000mg	1000mg	Tablet	120,946 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 1.5mg	1.5mg	Tablet, extended release	1,847,783 L.L
R06AX29	LABIXTEN	B	Bilastine - 2.5mg/ml	2.5mg/ml	Solution	463,626 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	692,079 L.L
A10BA02	GLUCOPHAGE XR	B	Metformin HCl - 1000mg	1000mg	Tablet, prolonged release	755,039 L.L
B05BA01	AMINOPLASMAL B. BRAUN	B	Amino acids - 10%	10%	Injectable solution	1,036,103 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	325,210 L.L
G01AF12	LOMEXIN	B	Fenticonazole nitrate - 600mg	600mg	Ovule	850,727 L.L
J02AA01	AMBISOME	B	Liposomal Amphotericin B - 50mg	50mg	Injectable powder for liposomal dispersion	13,126,040 L.L

...

168

...